Supply agreement for pharma packaging solution
Corning and Pfizer have executed a long-term purchase and supply agreement for Corning Valor glass. The multi-year agreement provides for the supply of Valor Glass vials to a portion of currently marketed Pfizer drug products, pending regulatory approval.
Since first launching its collaboration with Corning, Pfizer has continued to evaluate Valor Glass’ performance across several aseptic sites, utilising multiple vial sizes, with a broad range of drug products from Pfizer’s sterile injectables portfolio.
During this time, Valor Glass was accepted into and provisionally evaluated under the Food and Drug Administration’s Emerging Technology programme.
The packaging solution has been designed to enable superior chemical durability and resist breakage, damage and particulate contamination.
In addition, Valor Glass has a low-friction exterior coating that enhances manufacturing productivity by enabling increased throughput and quality assurance for pharmaceutical manufacturers.
